Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors - Concepedia

Concepedia

Publication | Open Access

Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors

DOI Full Paper Access

127

Citations

28

References

2016

Year

Xiumei Huang, Edward A. Motea, Zachary Moore, Jun Yao, Ying Dong, Gaurab Chakrabarti, Jessica A. Kilgore, Molly A. Silvers, Praveen Patidar, Agnieszka Cholka,

Nqo1 Bioactivatable DrugTumor BiologyPolymer-drug ConjugateMedicinePharmacologyTumor-selective UsePharmacotherapyPolymerase InhibitorsAnti-cancer AgentCancer TreatmentDrug DevelopmentOncologyRadiation OncologyCancer ResearchDrug Discovery

References

	Year	Citations

Page 1

Page 1